Flagship Pioneering’s Seres Therapeutics MCRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.8M Sell
1,155,850
-2
-0% -$22 4.78% 4
2025
Q1
$16.2M Hold
1,155,852
6.86% 4
2024
Q4
$19.3M Hold
1,155,852
5.76% 5
2024
Q3
$21.9M Hold
1,155,852
3.7% 5
2024
Q2
$16.7M Hold
1,155,852
1.98% 5
2024
Q1
$17.9M Hold
1,155,852
1.17% 6
2023
Q4
$32.4M Hold
1,155,852
2.45% 6
2023
Q3
$55M Hold
1,155,852
3.99% 5
2023
Q2
$111M Hold
1,155,852
4.94% 4
2023
Q1
$131M Hold
1,155,852
5.09% 3
2022
Q4
$129M Hold
1,155,852
4.13% 4
2022
Q3
$148M Buy
1,155,852
+436,912
+61% +$56.1M 6.25% 3
2022
Q2
$49.3M Hold
718,940
1.86% 7
2022
Q1
$102M Hold
718,940
2.4% 6
2021
Q4
$120M Hold
718,940
1.85% 7
2021
Q3
$100M Hold
718,940
1.05% 9
2021
Q2
$343M Sell
718,940
-14,759
-2% -$7.04M 4.38% 4
2021
Q1
$302M Hold
733,699
4.84% 4
2020
Q4
$360M Sell
733,699
-344,889
-32% -$169M 6.54% 3
2020
Q3
$611M Hold
1,078,588
16.87% 2
2020
Q2
$103M Hold
1,078,588
2.98% 6
2020
Q1
$77M Hold
1,078,588
3.61% 5
2019
Q4
$74.4M Hold
1,078,588
4.16% 5
2019
Q3
$86.5M Hold
1,078,588
4.73% 6
2019
Q2
$69.5M Buy
1,078,588
+444,444
+70% +$28.6M 3.01% 8
2019
Q1
$87.1M Hold
634,144
3.3% 6
2018
Q4
$57.3M Hold
634,144
2.8% 5
2018
Q3
$96.3M Hold
634,144
6.36% 4
2018
Q2
$109M Hold
634,144
20.89% 3
2018
Q1
$93.1M Hold
634,144
26.99% 2
2017
Q4
$129M Hold
634,144
32.61% 2
2017
Q3
$203M Hold
634,144
68.04% 1
2017
Q2
$143M Hold
634,144
50.54% 1
2017
Q1
$143M Hold
634,144
37.99% 1
2016
Q4
$126M Hold
634,144
40.85% 1
2016
Q3
$156M Buy
+634,144
New +$156M 42.59% 1